Compare FPH & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FPH | RXST |
|---|---|---|
| Founded | 2009 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 376.2M | 307.6M |
| IPO Year | 2013 | 2021 |
| Metric | FPH | RXST |
|---|---|---|
| Price | $5.45 | $7.68 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $11.50 |
| AVG Volume (30 Days) | 176.1K | ★ 813.3K |
| Earning Date | 04-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $237,926,000.00 | $134,479,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $8.69 |
| P/E Ratio | $11.40 | ★ N/A |
| Revenue Growth | ★ 12.37 | N/A |
| 52 Week Low | $4.58 | $6.62 |
| 52 Week High | $6.64 | $27.13 |
| Indicator | FPH | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 46.72 | 38.50 |
| Support Level | $5.36 | $7.08 |
| Resistance Level | $5.74 | $9.11 |
| Average True Range (ATR) | 0.20 | 0.52 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 35.63 | 26.61 |
Five Point Holdings LLC is an owner and developer of mixed-use, master-planned communities in California. It is engaged in developing new communities that, in addition to homesites, include commercial, retail, educational, and recreational elements, as well as civic areas, parks, and open spaces. Its three reportable segments are Valencia, San Francisco, and Great Park. It derives the majority of revenue from the Great Park segment which includes Great Park Neighborhoods being developed adjacent to and around the Orange County Great Park, a metropolitan park under construction in Orange County, California.
RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.